Oversee contract development and manufacturing organizations for drug substance process chemistry activities, focusing on late-stage and validation.
Author and manage RFP documents, support regulatory submissions, and provide technical expertise for manufacturing scale-up and troubleshooting.
Interface proactively with CMC team members and communicate process chemistry strategies effectively across departments.
BridgeBio pioneers a 'moneyball for biotech' approach, pooling projects and early-stage research from academia to reduce risk and develop life-changing medicines for rare diseases. The company fosters a culture of curiosity and experimentation, empowering teams to push boundaries and achieve the impossible.
Plan, prepare, and execute CMC regulatory activities for investigational and commercial small molecule and ASO programs.
Author and review CMC sections of regulatory submissions including INDs, NDAs, and post-approval supplements.
Coordinate with cross-functional teams and manage external vendors to support global submissions and health authority interactions.
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into therapies for central nervous system disorders. The company fosters a culture of trust, ownership, curiosity, and results, with a collaborative team focused on developing high-impact medicines.
Own drug substance technology transfer, MSAT, and manufacturing oversight for CDMO partners.
Lead process validation, commercialization, and lifecycle management for peptide DS manufacturing.
Build and develop high-performing teams while ensuring cGMP compliance and regulatory readiness.
Kailera Therapeutics is a biopharmaceutical company developing novel therapies for obesity and related conditions. The company fosters an entrepreneurial, team-oriented culture focused on collaboration, integrity, and excellence and is expanding its team.